 |
|
|
|
|
| |
 |
|
|
| |
Boston Millennia Partners’ portfolio reflects Millennia’s commitment towards building enduring, large-scale businesses that have the potential to provide superior financial returns to our investors. Millennia’s portfolio is comprised of a diversified group of firms each positioned with the potential to become leaders in their respective market segments. We invite you to use the links below to learn more about each of those portfolio companies. |
|
| |
|
|
| |
| |
|
| |
|
|
Arthrosurface, Inc.
28 Forge Parkway
Franklin, MA 02038
USA
Phone: 508-520-3003
Fax: 508-528-4604
|
|
| |
| |
Arthrosurface, Inc. was organized in 2002 to develop surgical alternatives for the treatment of orthopedic joint disease. Arthrosurface's initial efforts have resulted in the development of a new method to repair isolated articular cartilage defects and damage to major joints including the knees, hips and shoulders using minimal access surgical procedures. The Company's first focus relates to the application of the technology to convex joint surfaces such as the condyles of the knee, the head of the shoulder and the ball of the hip. The Company believes that its technology can also be adapted to repair concave surfaces such as the tibial plateau, the glenoid in the shoulder and other joint surfaces.
In a relatively short time ArthroSurface reduced concepts to practice, completed animal trials and obtained FDA 510K approval for the CAP™ system in the shoulder and hip. The company expects to shortly initiate clinical trials to obtain approval in the knee.
The CAP™ system is expected to give orthopedic surgeons a new treatment option for patients with certain types of joint disease. The system is expected to provide a substantially less invasive alternative to joint replacement surgery that also reduces or eliminates pain and restores quality of life. At the same time, the system will leave future treatment options intact.
Commercialization of the technology is in progress in the U.S. and is expected to commence in Europe in 2004. |
|
| |
|
| Millennia Team |
Pat Fortune, Ph.D.,
Brad Callow
|
|
| Visit the Website |
http://www.arthrosurface.com |
|
| Case Study |
Arthrosurface, located in Franklin, MA, develops and markets orthopedic devices for joint resurfacing. Boston Millennia Partners sourced this investment opportunity through proactive deal flow efforts. We have maintained our position as the sole institutional investor in Arthrosurface because we believe strongly in the future prospects for the company’s novel solutions in a rapidly expanding orthopedics market. The company has been growing rapidly, with surgeon usage and revenue growth rates over 400% cumulatively over the past three years. The company’s proprietary HemiCAP® (Contoured Articular Prosthetic) system is a unique, minimally invasive technology that can be used to treat a wide range of joint defects ranging from isolated defects on the joint’s articular surface to large articular surface lesions and osteochondral defects. Arthrosurface has developed a broad portfolio of FDA-approved implant devices for the shoulder, knee and hip joints, as well as the great toe and ankle joints. In addition, the Company has several implant devices under development targeting the knee (Uni) and glenoid surface of the shoulder. Arthrosurface markets and distributes its products in the U.S. and several countries outside of the U.S., including Germany, the U.K., Spain, Italy, Belgium, Australia, Canada and South Africa.
|
|
| Related News |
Franklin, MA - June 23, 2008
Arthrosurface Receives CE Mark Approval for Uni Knee Resurfacing System
Chicago Tribute Web Edition - June 3, 2008
Staying active with toe implant
Franklin, MA - November 27, 2006
More Than 1,000 Patients Receive the Arthrosurface Product for the Great Toe
Franklin, MA - October 3, 2006
Arthrosurface Patients Cross the Three Year Mark
Franklin, MA - August 14, 2006
Arthrosurface Launches New Product for Treatment of Patello-Femoral Disease
FRANKLIN, MA - February 10, 2005
Boston Millennia Partners Leads $10.5 million Fourth Round of Preferred Equity Financing in Arthrosurface.
Boston, MA – March 25, 2004
Boston Millennia Partners Leads $6M Round in ArthroSurface
Boston, Massachusetts - (Business Wire) – October 29, 2003
Boston Millennia Partners Invests in ArthroSurface
|
|
|
|
|
|
|
|
|
|
